Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.

The role of angiotensin II via the angiotensin type 1 or type 2 receptor in the development of cardiac hypertrophy was determined in adult male Sprague-Dawley rats subjected to coarctation of the abdominal aorta. Five groups of animals were studied: coarctation, coarctation plus DuP 753, coarctation plus PD 123319, sham plus DuP 753, or sham operation. Type 1 receptor blockade was accomplished with DuP 753 given in the drinking water and type 2 blockade with PD 123319 delivered by osmotic minipumps beginning with the day of surgery until 72 hours after aortic coarctation. Mean carotid blood pressures and the carotid-femoral artery blood pressure gradients were not different among coarctation, coarctation plus DuP 753, and coarctation plus PD 123319 animals. However, ratios of heart weight to body weight were higher in coarctation (4.95 +/- 0.8) or coarctation plus PD 123319 (4.52 +/- 0.5) than in sham animals (3.6 +/- 0.4; P < .005 and .05, respectively). In coarctation plus DuP 753-treated animals heart weight-body weight ratios were not different from sham or sham plus DuP 753 animals (3.9 +/- 0.4 versus 3.6 +/- 0.4 or 3.3 +/- 0.08, respectively). Type 1 receptor mRNA levels were significantly increased in the coarctation group, with the highest levels in the coarctation plus DuP 753 and sham plus DuP 753 groups. To determine whether growth factors were involved in the hypertrophic process, we measured transforming growth factor-beta 1 mRNA levels. Northern analysis demonstrated a twofold increase in coarctation animals compared with sham or coarctation plus DuP 753-treated animals.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Sadoshima,et al.  Critical Role of the AT1 Receptor Subtype , 2005 .

[3]  A. Everett,et al.  Ontogeny of type 1 angiotensin II receptor gene expression in the rat. , 1993, The Journal of clinical investigation.

[4]  J. Prost,et al.  Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. , 1992, Hypertension.

[5]  M. Sporn,et al.  Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1. , 1992, The Journal of clinical investigation.

[6]  K. Swedberg,et al.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.

[7]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[8]  R. Garcia,et al.  Chronic captopril and losartan (DuP 753) administration in rats with high-output heart failure. , 1992, The American journal of physiology.

[9]  R D Smith,et al.  Angiotensin II receptor subtypes. , 1992, American journal of hypertension.

[10]  F. Villarreal,et al.  Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. , 1992, The American journal of physiology.

[11]  D. Guo,et al.  Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. , 1992, Biochemical and biophysical research communications.

[12]  R. Chevalier,et al.  Hepatic Angiotensinogen Gene Regulation in the Fetal and Pregnant Rat1 , 1991, Pediatric Research.

[13]  J. Murray,et al.  Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor , 1991, Nature.

[14]  R. Alexander,et al.  Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor , 1991, Nature.

[15]  K. Baker,et al.  Cardiac Hypertrophy: Mechanical, Neural, and Endocrine Dependence , 1991 .

[16]  A. Schmid,et al.  Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium. , 1990, Biochemical and biophysical research communications.

[17]  M. Caron,et al.  Mechanisms involved in adrenergic receptor desensitization. , 1990, Biochemical Society transactions.

[18]  K. Baker,et al.  Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. , 1990, The American journal of physiology.

[19]  A. Roberts,et al.  cDNA cloning by PCR of rat transforming growth factor β-1 , 1990 .

[20]  T. Parker,et al.  Cardiac Myocytes as Targets for the Action of Peptide Growth Factors , 1990, Circulation.

[21]  Y. Yazaki,et al.  Stretching cardiac myocytes stimulates protooncogene expression. , 1990, The Journal of biological chemistry.

[22]  T. Parker,et al.  Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. , 1990, The Journal of clinical investigation.

[23]  J. Michel,et al.  Atrial natriuretic factor gene expression in rat ventricle during experimental hypertension. , 1989, The American journal of physiology.

[24]  H. Sharma.  Angiogenesis by slow coronary artery occlusion in the pig heart: Expression of different growth factors mRNAs , 1989 .

[25]  M. Sporn,et al.  Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice , 1989, The Journal of cell biology.

[26]  G. Riegger,et al.  Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. , 1988, The American journal of cardiology.

[27]  M. Caron,et al.  Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors. , 1988, Molecular pharmacology.

[28]  W. Kannel.  Epidemiology and prevention of cardiac failure: Framingham Study insights. , 1987, European heart journal.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[30]  R. Matsuoka,et al.  Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. , 1987, The Journal of clinical investigation.

[31]  T. Kao,et al.  Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. , 1985, Nucleic acids research.

[32]  K. Hammermeister,et al.  Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. , 1979, Circulation.

[33]  M. Beznák.  Changes in heart weight and blood pressure following aortic constriction in rats. , 1955, Canadian journal of biochemistry and physiology.

[34]  G. Church,et al.  Genomic sequencing. , 1993, Methods in molecular biology.

[35]  B. Nadal-Ginard,et al.  Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[36]  F. Dunn,et al.  Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. , 1984, The American journal of cardiology.